clinisys scotland limited Company Information
Company Number
SC065358
Website
www.clinisys.co.ukRegistered Address
third floor 2 semple street, edinburgh, city of edinburgh, EH3 8BL
Industry
Business and domestic software development
Telephone
01413529000
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
medical information professional systems nv 100%
clinisys scotland limited Estimated Valuation
Pomanda estimates the enterprise value of CLINISYS SCOTLAND LIMITED at £0 based on a Turnover of £0 and 0.82x industry multiple (adjusted for size and gross margin).
clinisys scotland limited Estimated Valuation
Pomanda estimates the enterprise value of CLINISYS SCOTLAND LIMITED at £16k based on an EBITDA of £2.9k and a 5.54x industry multiple (adjusted for size and gross margin).
clinisys scotland limited Estimated Valuation
Pomanda estimates the enterprise value of CLINISYS SCOTLAND LIMITED at £8.5m based on Net Assets of £3.8m and 2.24x industry multiple (adjusted for liquidity).
Clinisys Scotland Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Clinisys Scotland Limited Overview
Clinisys Scotland Limited is a live company located in city of edinburgh, EH3 8BL with a Companies House number of SC065358. It operates in the business and domestic software development sector, SIC Code 62012. Founded in July 1978, it's largest shareholder is medical information professional systems nv with a 100% stake. Clinisys Scotland Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Clinisys Scotland Limited Health Check
Pomanda's financial health check has awarded Clinisys Scotland Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 2 areas for improvement. Company Health Check FAQs
3 Strong
0 Regular
2 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Clinisys Scotland Limited
- - Industry AVG
Growth
3 year (CAGR) sales growth of -100%, show it is growing at a slower rate (7.7%)
- - Clinisys Scotland Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Clinisys Scotland Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Clinisys Scotland Limited
- - Industry AVG
Employees
with 43 employees, this is above the industry average (32)
- - Clinisys Scotland Limited
- - Industry AVG
Pay Structure
on an average salary of £35.5k, the company has a lower pay structure (£67.5k)
- - Clinisys Scotland Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- - Clinisys Scotland Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Clinisys Scotland Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Clinisys Scotland Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Clinisys Scotland Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 3 weeks, this is less cash available to meet short term requirements (19 weeks)
- - Clinisys Scotland Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 13.5%, this is a lower level of debt than the average (62%)
- - Clinisys Scotland Limited
- - Industry AVG
clinisys scotland limited Credit Report and Business Information
Clinisys Scotland Limited Competitor Analysis
Perform a competitor analysis for clinisys scotland limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
clinisys scotland limited Ownership
CLINISYS SCOTLAND LIMITED group structure
Clinisys Scotland Limited has no subsidiary companies.
Ultimate parent company
ROPER INTERNATIONAL HOLDING INC
#0145786
MEDICAL INFORMATION PROFESSIONAL SYSTEMS
#0072306
2 parents
CLINISYS SCOTLAND LIMITED
SC065358
clinisys scotland limited directors
Clinisys Scotland Limited currently has 4 directors. The longest serving directors include Mr John Stipancich (Dec 2016) and Mr Robert Crisci (Apr 2017).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr John Stipancich | United States | 55 years | Dec 2016 | - | Director |
Mr Robert Crisci | United States | 48 years | Apr 2017 | - | Director |
Mr Jason Conley | United States | 48 years | Apr 2017 | - | Director |
Mr Michael Simpson | United Kingdom | 58 years | Mar 2019 | - | Director |
CLINISYS SCOTLAND LIMITED financials
Clinisys Scotland Limited's latest turnover from December 2022 is 0 and the company has net assets of £3.8 million. According to their latest financial statements, Clinisys Scotland Limited has 43 employees and maintains cash reserves of £33.8 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 0 | 4,913,136 | 4,377,115 | 4,452,155 | 4,087,000 | 3,970,000 | 3,349,000 | 3,586,000 | 3,724,000 | 3,613,000 | 3,715,000 | 3,396,000 | 3,189,000 | 3,381,000 |
Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost Of Sales | 0 | 991,328 | 909,649 | 1,246,975 | 761,000 | 786,000 | 779,000 | 688,000 | 820,000 | 732,000 | 721,000 | 675,000 | 477,000 | 845,000 |
Gross Profit | 0 | 3,921,808 | 3,467,466 | 3,205,180 | 3,326,000 | 3,184,000 | 2,570,000 | 2,898,000 | 2,904,000 | 2,881,000 | 2,994,000 | 2,721,000 | 2,712,000 | 2,536,000 |
Admin Expenses | 0 | 1,309,363 | 1,425,765 | 1,335,323 | 1,366,000 | 1,442,000 | 1,105,000 | 1,524,000 | 1,394,000 | 1,455,000 | 1,375,000 | 1,363,000 | 1,512,000 | 1,471,000 |
Operating Profit | 0 | 2,612,445 | 2,041,701 | 1,869,857 | 1,960,000 | 1,742,000 | 1,465,000 | 1,374,000 | 1,510,000 | 1,426,000 | 1,619,000 | 1,358,000 | 1,200,000 | 1,065,000 |
Interest Payable | 0 | 3,897 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Pre-Tax Profit | -16,743,597 | 2,608,548 | 2,041,701 | 1,869,857 | 1,960,000 | 1,742,000 | 1,465,000 | 1,374,000 | 1,510,000 | 1,426,000 | 1,619,000 | 1,358,000 | 1,200,000 | 1,065,000 |
Tax | -1,055 | -63,013 | -327,937 | -145,276 | -375,000 | 1,000 | 20,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | -16,744,652 | 2,545,535 | 1,713,764 | 1,724,581 | 1,585,000 | 1,743,000 | 1,485,000 | 1,374,000 | 1,510,000 | 1,426,000 | 1,619,000 | 1,358,000 | 1,200,000 | 1,065,000 |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Retained Profit | -16,744,652 | 2,545,535 | 1,713,764 | 1,724,581 | 1,585,000 | 1,743,000 | 1,485,000 | 1,374,000 | 1,510,000 | 1,426,000 | 1,619,000 | 1,358,000 | 1,200,000 | 1,065,000 |
Employee Costs | 1,524,530 | 1,945,715 | 1,722,702 | 1,622,263 | 1,577,000 | 1,659,000 | 1,281,000 | 1,663,000 | 1,581,000 | 1,536,000 | 1,486,000 | 1,456,000 | 1,468,000 | 1,603,000 |
Number Of Employees | 43 | 36 | 34 | 33 | 33 | 31 | 32 | 31 | 31 | 31 | 30 | 31 | 32 | |
EBITDA* | 2,898 | 2,619,408 | 2,057,145 | 1,889,732 | 1,979,000 | 1,764,000 | 1,482,000 | 1,392,000 | 1,545,000 | 1,464,000 | 1,656,000 | 1,379,000 | 1,216,000 | 1,091,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 0 | 2,898 | 9,861 | 18,355 | 35,000 | 47,000 | 63,000 | 12,000 | 29,000 | 50,000 | 65,000 | 47,000 | 33,000 | 15,000 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,000 | 2,000 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 17,856 | 18,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 0 | 2,898 | 9,861 | 36,211 | 53,000 | 47,000 | 63,000 | 13,000 | 31,000 | 50,000 | 65,000 | 47,000 | 33,000 | 15,000 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group Debtors | 4,273,734 | 26,213,633 | 23,833,735 | 21,642,292 | 19,775,000 | 17,818,000 | 16,217,000 | 14,754,000 | 13,322,000 | 11,733,000 | 10,329,000 | 8,650,000 | 7,564,000 | 6,410,000 |
Misc Debtors | 95,669 | 125,410 | 110,601 | 145,861 | 167,000 | 129,000 | 144,000 | 87,000 | 72,000 | 131,000 | 87,000 | 77,000 | 86,000 | 167,000 |
Cash | 33,808 | 41,995 | 31,219 | 93,544 | 77,000 | 161,000 | 50,000 | 50,000 | 115,000 | 156,000 | 118,000 | 243,000 | 39,000 | 37,000 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 4,403,211 | 26,381,038 | 23,975,555 | 21,881,697 | 20,019,000 | 18,108,000 | 16,411,000 | 14,891,000 | 13,509,000 | 12,020,000 | 10,534,000 | 8,970,000 | 7,689,000 | 6,614,000 |
total assets | 4,403,211 | 26,383,936 | 23,985,416 | 21,917,908 | 20,072,000 | 18,155,000 | 16,474,000 | 14,904,000 | 13,540,000 | 12,070,000 | 10,599,000 | 9,017,000 | 7,722,000 | 6,629,000 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 0 | 1,655 | 5,869 | 45,335 | 49,000 | 26,000 | 54,000 | 62,000 | 70,000 | 105,000 | 52,000 | 48,000 | 72,000 | 33,000 |
Group/Directors Accounts | 0 | 5,137,490 | 5,137,490 | 5,137,488 | 5,138,000 | 5,037,000 | 5,037,000 | 5,038,000 | 5,038,000 | 5,038,000 | 5,080,000 | 5,079,000 | 5,079,000 | 5,079,000 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 532,462 | 528,617 | 655,983 | 392,775 | 268,000 | 61,000 | 95,000 | 51,000 | 53,000 | 58,000 | 24,000 | 66,000 | 105,000 | 251,000 |
total current liabilities | 532,462 | 5,667,762 | 5,799,342 | 5,575,598 | 5,455,000 | 5,124,000 | 5,186,000 | 5,151,000 | 5,161,000 | 5,201,000 | 5,156,000 | 5,193,000 | 5,256,000 | 5,363,000 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 63,792 | 164,565 | 180,000 | 50,000 | 50,000 | 50,000 | 50,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 63,792 | 164,565 | 180,000 | 50,000 | 50,000 | 50,000 | 50,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total liabilities | 596,254 | 5,832,327 | 5,979,342 | 5,625,598 | 5,505,000 | 5,174,000 | 5,236,000 | 5,151,000 | 5,161,000 | 5,201,000 | 5,156,000 | 5,193,000 | 5,256,000 | 5,363,000 |
net assets | 3,806,957 | 20,551,609 | 18,006,074 | 16,292,310 | 14,567,000 | 12,981,000 | 11,238,000 | 9,753,000 | 8,379,000 | 6,869,000 | 5,443,000 | 3,824,000 | 2,466,000 | 1,266,000 |
total shareholders funds | 3,806,957 | 20,551,609 | 18,006,074 | 16,292,310 | 14,567,000 | 12,981,000 | 11,238,000 | 9,753,000 | 8,379,000 | 6,869,000 | 5,443,000 | 3,824,000 | 2,466,000 | 1,266,000 |
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | 0 | 2,612,445 | 2,041,701 | 1,869,857 | 1,960,000 | 1,742,000 | 1,465,000 | 1,374,000 | 1,510,000 | 1,426,000 | 1,619,000 | 1,358,000 | 1,200,000 | 1,065,000 |
Depreciation | 2,898 | 6,963 | 15,444 | 19,875 | 19,000 | 22,000 | 16,000 | 17,000 | 34,000 | 38,000 | 37,000 | 21,000 | 16,000 | 26,000 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 1,000 | 1,000 | 1,000 | 0 | 0 | 0 | 0 | 0 |
Tax | -1,055 | -63,013 | -327,937 | -145,276 | -375,000 | 1,000 | 20,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | -21,969,640 | 2,394,707 | 2,138,327 | 1,846,009 | 2,013,000 | 1,586,000 | 2,967,000 | 1,447,000 | 1,530,000 | 1,448,000 | 1,689,000 | 1,077,000 | 1,073,000 | 6,577,000 |
Creditors | -1,655 | -4,214 | -39,466 | -3,665 | 23,000 | -28,000 | -16,000 | -8,000 | -35,000 | 53,000 | 4,000 | -24,000 | 39,000 | 33,000 |
Accruals and Deferred Income | 3,845 | -127,366 | 263,208 | 124,775 | 207,000 | -34,000 | 42,000 | -2,000 | -5,000 | 34,000 | -42,000 | -39,000 | -146,000 | 251,000 |
Deferred Taxes & Provisions | -100,773 | -15,435 | 130,000 | 0 | 0 | 0 | 50,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | 21,872,900 | 14,673 | -55,377 | 19,557 | -179,000 | 117,000 | -1,389,000 | -65,000 | -25,000 | 103,000 | -71,000 | 239,000 | 36,000 | -5,202,000 |
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | -5,137,490 | 0 | 2 | -512 | 101,000 | 0 | -1,000 | 0 | 0 | -42,000 | 1,000 | 0 | 0 | 5,079,000 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | ||||||||||||||
interest | 0 | -3,897 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from financing | -5,137,490 | -3,897 | 2 | 217 | 102,000 | 0 | 1,373,000 | 0 | 0 | -42,000 | 1,000 | 0 | 0 | 5,280,000 |
cash and cash equivalents | ||||||||||||||
cash | -8,187 | 10,776 | -62,325 | 16,544 | -84,000 | 111,000 | -65,000 | -65,000 | -41,000 | 38,000 | -125,000 | 204,000 | 2,000 | 37,000 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -8,187 | 10,776 | -62,325 | 16,544 | -84,000 | 111,000 | -65,000 | -65,000 | -41,000 | 38,000 | -125,000 | 204,000 | 2,000 | 37,000 |
P&L
December 2022turnover
0
-100%
operating profit
0
-100%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
3.8m
-0.81%
total assets
4.4m
-0.83%
cash
33.8k
-0.19%
net assets
Total assets minus all liabilities
clinisys scotland limited company details
company number
SC065358
Type
Private limited with Share Capital
industry
62012 - Business and domestic software development
incorporation date
July 1978
age
46
accounts
Full Accounts
ultimate parent company
previous names
torex laboratory systems limited (May 2005)
berkeley computer services limited (June 2002)
incorporated
UK
address
third floor 2 semple street, edinburgh, city of edinburgh, EH3 8BL
last accounts submitted
December 2022
clinisys scotland limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 11 charges/mortgages relating to clinisys scotland limited. Currently there are 0 open charges and 11 have been satisfied in the past.
clinisys scotland limited Companies House Filings - See Documents
date | description | view/download |
---|